(Q52926628)
Statements
Pretreatment levels of sTNF-R1 and sIL-6R are associated with a higher vulnerability for IFN-alpha-induced depressive symptoms in patients with malignant melanoma. (English)
Astrid Friebe
Markus J Schwarz
Monika Schmid-Wendtner
Matthias Volkenandt
Folkhart Schmidt
Martin Horn
Gesa Janssen
Martin Schaefer
1 April 2007
30
3
333-337